Rapport Therapeutics Announces Pricing of Initial Public

BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on...

Related Keywords

New York ,United States ,San Francisco ,California ,Boston ,Massachusetts ,Julie Dicarlo ,Exchange Commission ,Goldman Sachs Co ,Rapport Therapeutics Inc ,Prospectus Department ,Nicolaus Company Incorporated ,Head Of Communications ,Nasdaq ,Equity Syndicate Prospectus Department ,Td Securities United States ,Nasdaq Global Market ,Securities Act ,Goldman Sachs ,One Montgomery Street ,